Tus-Pharmaceutical Group News

Enlightenment Pharmaceutical: Announcement on capital increase to the wholly-owned subsidiary Guhan Traditional Chinese Medicine Co., Ltd.

Nov 23 00:00

Enlighten Pharmaceutical: Announcement on the Appointment of the Company\'s Senior Management

Oct 30 00:00

Enlightenment Pharmaceutical: Announcement on capital increase to wholly-owned subsidiary

Oct 30 00:00

Enlightenment Pharmaceutical: Announcement on receiving a notice from shareholders of Mingshi Pharmaceutical to terminate the share transfer

Sep 5 00:00

Enlightenment Pharmaceutical: 2024 Semi-Annual Financial Report

Aug 29 00:00

Enlighten Pharmaceutical: Announcement on the Appointment of the Company\'s Securities Affairs Representative

Aug 29 00:00

Enlightenment Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary

Aug 29 00:00

Tus-Pharmaceutical Group: Announcement regarding the pledge of a portion of the equity of one of the controlling shareholders by the concerted action person.

Jul 27 00:00

Tus-Pharmaceutical Group: Announcement Regarding Appointment of Secretary of the Board of Directors

Jul 6 00:00

Tus-Pharmaceutical Group: Announcement regarding the resignation of the company's vice president and board of directors secretary.

Jul 2 00:00

Tus-Pharmaceutical Group: Legal opinion on the 2023 shareholder meeting of Tus-Pharmaceutical Group Co., Ltd.

Jun 29 00:00

Tus-Pharmaceutical Group: Announcement of resolutions of the 2023 Shareholders' Meeting (2024-027)

Jun 29 00:00

Tus-Pharmaceutical Group: Announcement on amending the Company's Articles of Association.

Jun 7 00:00

Tus-Pharmaceutical Group: Notice on holding the shareholder meeting for the year 2023.

Jun 7 00:00

Tus-Pharmaceutical Group: Internal Audit Management Standards

Jun 7 00:00

Tus-Pharmaceutical Group: Materials for the 2023 Shareholders' Meeting.

Jun 7 00:00

Enlightenment Pharmaceutical: Announcement on the pledge of some of the shares of the controlling shareholders\' concerted actions

Apr 9 00:00

Enlighten Pharmaceutical: Report on the Audit Committee of the Board of Directors on the performance of supervisory duties by accounting firms in 2023

Mar 28 00:00

Enlighten Pharmaceutical: Sensitive Information Investigation System (revised in March 2024)

Mar 28 00:00

Enlighten Pharmaceutical: Announcement on the Company's Accumulation of Goodwill Impairment Preparation

Mar 28 00:00